HomeCompareHTSUF vs PLD

HTSUF vs PLD: Dividend Comparison 2026

HTSUF yields 2.10% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $5.88M in total portfolio value
10 years
HTSUF
HTSUF
● Live price
2.10%
Share price
$29.00
Annual div
$0.61
5Y div CAGR
6.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.1K
Annual income
$469.34
Full HTSUF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — HTSUF vs PLD

📍 PLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHTSUFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HTSUF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HTSUF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HTSUF
Annual income on $10K today (after 15% tax)
$178.79/yr
After 10yr DRIP, annual income (after tax)
$398.94/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, PLD beats the other by $4,037,717.47/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HTSUF + PLD for your $10,000?

HTSUF: 50%PLD: 50%
100% PLD50/50100% HTSUF
Portfolio after 10yr
$2.97M
Annual income
$2,375,597.26/yr
Blended yield
80.09%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

HTSUF
No analyst data
Altman Z
4.8
Piotroski
6/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HTSUF buys
0
PLD buys
0
No recent congressional trades found for HTSUF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHTSUFPLD
Forward yield2.10%3.10%
Annual dividend / share$0.61$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR6.4%74.4%
Portfolio after 10y$24.1K$5.91M
Annual income after 10y$469.34$4,750,725.19
Total dividends collected$3.3K$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: HTSUF vs PLD ($10,000, DRIP)

YearHTSUF PortfolioHTSUF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$10,924$223.81$11,241$540.96$317.00PLD
2$11,932$243.11$13,019$991.13$1.1KPLD
3$13,031$264.05$15,801$1,870.97$2.8KPLD
4$14,230$286.76$20,609$3,701.21$6.4KPLD
5$15,537$311.39$29,919$7,867.97$14.4KPLD
6$16,963$338.09$50,631$18,617.74$33.7KPLD
7$18,517$367.05$105,528$51,352.20$87.0KPLD
8$20,212$398.44$287,364$174,449.42$267.2KPLD
9$22,059$432.46$1,081,760$774,280.77$1.06MPLD
10$24,073$469.34$5,908,209$4,750,725.19$5.88MPLD

HTSUF vs PLD: Complete Analysis 2026

HTSUFStock

Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. The company provides external pain relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; and BUTENALOCK, a remedy for athlete's foot, as well as ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, transdermal analgesic anti-inflammatory drug; patches for female hormone, asthma treatment, and treatment for overactive bladders. In addition, the company manufactures and sells drugs under MOHRUS TAPE, MOHRUS PAP XR, FENTOS Tapes, NEOXY Tapes, Abstral, ALLESAGA Tapes, HARUROPI Tapes, and MENOAID Combipatch. Further, it provides HFT-290, a transdermal patch for cancer pain. The company sells its products in the United States and Asia. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.

Full HTSUF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this HTSUF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HTSUF vs SCHDHTSUF vs JEPIHTSUF vs OHTSUF vs KOHTSUF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.